EP3148513
CERITINIB FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2015EP published:
26.2.2020EP application number:
15727470.5
EPO information:
European Patent Register
Max expiry date:
26.5.2035
Title:
CERITINIB FORMULATION
Timeline
Today
27.5.2015EP application
26.2.2020EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
BREULLES, SebastienAddress:
4002 Basel, CH
Name:
ENSSLIN, SimonAddress:
4002 Basel, CH
Priority
Number:
201462004359 PDate:
29.5.2014Country:
US
Classification
Categories:
A61K 9/20, A61K 9/16, A61K 31/435, A61K 31/506